Patient | Age | Sex | Tumor | Prev. treatment | Tumor stage | Outcome (weeks) |
---|---|---|---|---|---|---|
Mixed breed | 10 | FS | Metastatic Anal sac Ca (sublumbar lymph nodes) | Surgery | T0 N1 MX | PR 40 |
Mixed breed | 12 | FS | Metastatic Anal sac Ca (sublumbar lymph nodes) | Surgery | T0 N1 MX | CR 56 |
Mixed breed | 16 | FS | Thyroid Ca | Biopsy | T3B N0 MX | PD |
Cocker Spaniel | 6 | MC | Liver Sarcoma | Biopsy | T2 N0 MX | PR 30 |
Dachshund | 13 | MC | Liver Ca | Biopsy | T2 N0 MX | CR 90+ |
Golden retriever | 14 | MC | Ruptured | Surgery | T3 N0 MX | NED 72 |
Splenic HSA | ||||||
Labrador retriever | 12 | MC | Ruptured | Surgery | T3 N0 MX | NED 34 |
Splenic HSA | ||||||
Golden retriever | 13 | FS | Recurring inflammatory mammary Ca | Surgery | T4 N0 MX | CR 104+ |
Golden retriever | 10 | FS | Recurring inflammatory mammary Ca | Surgery | T4 N0 MX | PD |
Boxer | 10 | FS | Metastatic mammary Ca (axillary lymph node) | Biopsy | T3 N1 MX | PR 32 |
Dachshund | 13 | MC | Limb Sarcoma | Biopsy | T3 N0 MX | CR 20 |
Labrador retriever | 11 | M | Recurring | Surgery | T2 N0 MX | NED 30 |
Neck Sarcoma | ||||||
Mixed breed | 13 | FS | Nasal sinus AdCa | Biopsy | T3 N0 MX | PR 24+ |
Labrador | 10 | FS | Nasal Sarcoma | Electrochemotherapy | T3 N0 MX | PR 20+ |
Tibetan spaniel | 11 | M | Nasal carcinoma | Biopsy | T3 N0 MX | PR 8 |
Visla | 10 | M | Nasal carcinoma | Biopsy | T2 N0 MX | PR16+ |
Mixed breed | 10 | F | Lingual SCC | Biopsy | T2 N1A MX | PR 16+ |
Mixed breed | 12 | FS | Lung carcinoma | Biopsy | T1 NX MX | SD 16+ |
Mixed breed | 13 | F | Lung carcinoma | Biopsy | T1 NX MX | PR 12 |
German Shepherd | 10 | M | Visceral histiocytosis | Biopsy | T3 N1 MX | PD |
German shepherd | 9 | M | OSA | Biopsy | T2 NX MX | PD |
Rottweiler | 8 | M | OSA | Biopsy | T2 NX MX | SD 8+ |
DSH | 10 | FS | Nasal CSA | Biopsy | T2 N0 MX | PR 100 |
DSH | 10 | FS | Recurring anaplastic mammary carcinoma | Surgery | T4 N0 MX | NED 54+ |